{
    "Trade/Device Name(s)": [
        "AG-608N Single Blood Glucose Monitoring System",
        "AG-608N MULTI Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Andon Medical Co., Ltd.",
    "510(k) Number": "K110017",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093262"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "December 19, 2011",
    "Summary Letter Received Date": "December 19, 2011",
    "Submission Date": "December 30, 2010",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AG-608N Single Blood Glucose Meter",
        "AG-608N MULTI Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry",
        "Biosensor (Electrode)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Andon Medical AG-608N Single and MULTI Blood Glucose Monitoring Systems for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertips, palm, forearm, upper arm, calf, and thigh; single system for self-testing by one person at home, MULTI system for multiple-patient use in professional healthcare settings, both as aids to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}